Federal contractor · SAN DIEGO, CA

ABTERRA BIOSCIENCES, INC.

No contract obligations recorded for ABTERRA BIOSCIENCES, INC. in FY2026. Since FY2020: $555.6K. It also received $306.6K in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
TYHDLNB65NJ1
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 540.6KFY2020
  2. 15KFY2021
  3. 0FY2022

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for ABTERRA BIOSCIENCES, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ABTERRA BIOSCIENCES, INC. received $306.6K in federal assistance in FY2026, on 2 actions (1 new awards), −70% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($306.6K).

Assistance · FY2026
$306.6K
New awards
1
Actions
2
Since FY2021
$5.2M

Assistance by fiscal year

  1. 2.2MFY2021
  2. 748.8KFY2022
  3. 0FY2023
  4. 856.4KFY2024
  5. 1MFY2025
  6. 306.6KFY2026

By type

  1. Grants$306.6K100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$306.6K100%

Awarding agencies

  1. National Institutes of Health$306.6K100%
    Department of Health and Human Services

Largest awards

  1. REPTOR: ACCELERATING ANTIBODY DISCOVERY AND IMPROVING HITS WITH MACHINE LEARNING - ANTIBODY THERAPEUTICS ARE BECOMING INCREASINGLY…$1.9M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 19, 2024 – Jun 8, 2026· R44GM137688
  2. A PLATFORM FOR SERUM ANTIBODY REPERTOIRE ANALYSIS FOR AUTOIMMUNE DISEASE DIAGNOSIS - SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A CHRONIC…$306.6K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 17, 2026 – Aug 17, 2026· R43AI197772

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.